Rohto Pharmaceutical ,Ltd. Receivables

Rohto Pharmaceutical ,Ltd. (4527.T) currently reports a receivables of $70B as of June 2026. That compares with $67B in the prior-year period — up 5.3% year over year. Use the charts on this page to explore Rohto Pharmaceutical ,Ltd.'s receivables history and peer comparisons.

Rohto Pharmaceutical ,Ltd.'s receivables increased from $67B to $70B — a 5.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rohto Pharmaceutical ,Ltd. reported $70B in receivables as of June 2026. That compares with $67B in the prior-year period — up 5.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $70B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rohto Pharmaceutical ,Ltd., and consider following 4527.T for alerts when major investors trade the stock.